samedan logo
 
 
 
spacer
home > pmps > summer 2003 > combating internet distribution of counterfeit pharmaceuticals
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Combating Internet Distribution of Counterfeit Pharmaceuticals

Suspect distribution of pharmaceuticals online provides an ideal outlet for rogue manufacturers to sell counterfeit medications to the unsuspecting public with a high degree of anonymity. Internet pharmacies offer privacy, convenience and low prices. The combined impacts on consumer safety and pharmaceutical firms' profitability from Internet-supplied counterfeit products could be devastating.

According to a study prepared for this article, leading pharmaceutical brands promoted heavily online are exposed to suspect distribution on the Internet. This intelligence about suspect distribution of major branded pharmaceutical products is a key indicator of exposure to counterfeit risks. The sample set of five brands examines over 8,000 different websites for product promotions that appeal to lifestyle users or those that may self medicate. The research has also identified links between suspect distribution and extreme Internet activities such as pornography and gambling.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Kristofer Peterson, Internet Intelligence Consultant at New Vantage Limited

Kristofer Peterson is Internet Intelligence Consultant at New Vantage. He has been working in the Internet intelligence sector for nearly three years, initially with Infonic and then with Cyveillance. During this time he has developed expertise in the ways in which Internet exposure can present both challenges and opportunities for major corporations, and the ways this exposure may be tracked and managed. Kristofer studied Business at the London School of Economics following receipt of a BA in Politics from Whitman College in the US.

spacer
Kristofer Peterson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Memo Therapeutics AG collaborate on the fast-track manufacturing of a SARS-CoV-2- neutralizing antibody for the therapy of COVID-19

Vilnius, Lithuania, and Schlieren, Switzerland August 11, 2020 Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Swiss biotech company Memo Therapeutics AG (MTx), announce a new partnership to manufacture MTxs therapeutic COVID-19 antibody candidate in a 4-month fast-track process approved by regulatory authorities.
More info >>

White Papers

galenIQ - The smart excipient

BENEO GmbH

galenIQ combines a multitude of outstanding characteristics and is suitable for a wide range of pharmaceutical applications. galenIQ can be used as more than just a bulk excipient. It also serves as an anti-caking agent, anti-humectant agent, stabilizer or oral care and taste agent to mention just a few additional functions.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement